80 related articles for article (PubMed ID: 2505024)
21. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.
Walker BD; Kowalski M; Goh WC; Kozarsky K; Krieger M; Rosen C; Rohrschneider L; Haseltine WA; Sodroski J
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8120-4. PubMed ID: 2825177
[TBL] [Abstract][Full Text] [Related]
22. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.
Koga Y; Sasaki M; Yoshida H; Wigzell H; Kimura G; Nomoto K
J Immunol; 1990 Jan; 144(1):94-102. PubMed ID: 2404066
[TBL] [Abstract][Full Text] [Related]
23. A unique human immunodeficiency virus culture secreting soluble gp160.
Kalyanaraman VS; Pal R; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):319-29. PubMed ID: 3264172
[TBL] [Abstract][Full Text] [Related]
24. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
[TBL] [Abstract][Full Text] [Related]
25. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
26. Properties of virus-like particles produced by SIV-chronically infected human cell clones.
Kraiselburd EN; Torres JV
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S41-52. PubMed ID: 8574147
[TBL] [Abstract][Full Text] [Related]
27. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.
Matthews TJ; Weinhold KJ; Lyerly HK; Langlois AJ; Wigzell H; Bolognesi DP
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5424-8. PubMed ID: 3037551
[TBL] [Abstract][Full Text] [Related]
28. Persistent coinfection of T lymphocytes with HTLV-II and HIV and the role of syncytium formation in HIV-induced cytopathic effect.
Montefiori DC; Mitchell WM
Virology; 1987 Oct; 160(2):372-8. PubMed ID: 2821680
[TBL] [Abstract][Full Text] [Related]
29. Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities.
Andeweg AC; Groenink M; Leeflang P; de Goede RE; Osterhaus AD; Tersmette M; Bosch ML
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1803-13. PubMed ID: 1457193
[TBL] [Abstract][Full Text] [Related]
30. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
31. HIV infection is blocked in vitro by recombinant soluble CD4.
Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
[TBL] [Abstract][Full Text] [Related]
32. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
33. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids.
Tersmette M; van Dongen JJ; Clapham PR; de Goede RE; Wolvers-Tettero IL; Geurts van Kessel A; Huisman JG; Weiss RA; Miedema F
Virology; 1989 Feb; 168(2):267-73. PubMed ID: 2464872
[TBL] [Abstract][Full Text] [Related]
35. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).
Harada S; Kobayashi N; Koyanagi Y; Yamamoto N
Virology; 1987 Jun; 158(2):447-51. PubMed ID: 2438845
[TBL] [Abstract][Full Text] [Related]
36. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Tersmette M; de Goede RE; Al BJ; Winkel IN; Gruters RA; Cuypers HT; Huisman HG; Miedema F
J Virol; 1988 Jun; 62(6):2026-32. PubMed ID: 3130494
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1.
Schutten M; Andeweg AC; Bosch ML; Osterhaus AD
Scand J Immunol; 1995 Jan; 41(1):18-22. PubMed ID: 7824885
[TBL] [Abstract][Full Text] [Related]
39. The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1.
Meylan PR; Baumgartner M; Ciuffi A; Munoz M; Sahli R
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1531-42. PubMed ID: 9840286
[TBL] [Abstract][Full Text] [Related]
40. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
